Pharma News

Smokers looking for Pfizer's cessation med Chantix may have a tough time finding the drug as the pharma giant has halted global distribution on impurity concerns.

Nearly 17 million people — about five times more than official counts — may have had undiagnosed COVID-19 infections in the U.

Biogen has hinted that it may consider altering the price of its controversially-approved Alzheimer’s therapy Aduhelm – but only if its assumptions on population size and uptake are different from...

Eli Lilly plans to file for accelerated approval of its Alzheimer’s disease prospect donanemab later this year.

June 23 (Businesshala) – GSK (GSK.

Artificial intelligence is to be used to tackle the most deadly parasitic diseases in the developing world, tech company DeepMind has announced.

The American company Moderna has changed the name of its coronavirus vaccine, it follows from the data of the European Medicines Agency (EMA).

For many, mRNA-based medicines are synonymous with COVID-19 vaccines, but vaccination is just the tip of the iceberg for the technology.

In rapidly developing a COVID-19 vaccine—and a highly effective one at that—Novavax got the hard part right.

As Bristol Myers Squibb looks to guard Celgene’s top-selling cancer drug Revlimid from copycat competition, the company has inked a series of deals to welcome generic challengers in waves.

As Legend Biotech and Johnson & Johnson's multiple myeloma cell therapy prospect nears the FDA finish line, the companies are moving to carve out a manufacturing foothold in Europe.

The European Commission (EC) has granted AstraZeneca (AZ) and MSD’s Koselugo (selumetinib) a conditional approved for the treatment of children with symptomatic, inoperable p...